Best Life Sciences Companies in Dublin, Ireland
The 129 best Life Sciences companies in Dublin, Ireland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Avadel Pharmaceuticals.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Dublin
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Avadel Pharmaceuticals Pharma company with proprietary drug delivery tools and drug for narcolepsy | $326M | 51 mo ago | 74 74 → 156 (+111%) | Gregory Divis CEO | DrupalApple iCloud MailPHP+26 | — | — |
| 2 | Jazz Pharmaceuticals Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 203 mo ago | 831 | Bruce Cozadd Co-Founder & CEO | DrupalPHPSalesforce+26 | 445 patents Patents concentrated in health & consumer products | 1 partnership |
| 3 | GC Aesthetics Developer of silicone breast implants for breast reconstruction | $233M | 91 mo ago | 259 | Carlos Pinto Chief Executive Officer | Node.jsVuetifyGoogle Cloud+15 | — | — |
| 4 | Juvenescence Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health | $214M | 13 mo ago | 38 | Greg Bailey Co-Founder & CEO | WordPressApple iCloud MailMicrosoft 365+21 | 2 patents Digital health data analytics platforms for personalized medical information management | — |
| 5 | Amryt Pharma Developer of therapeutics for treating rare dermatological diseases | $145M | 66 mo ago | 266 | Joe Wiley CEO | WordPress Block EditorwpBakeryElementor+35 | — | — |
| 6 | Iterum Therapeutics Developer of antibiotics for MDR infections | $126M | 71 mo ago | 7 | — | HighstockBootstrapApache HTTP Server+12 | 37 patents Enhanced beta‑lactam antibiotic formulations with probenecid (and valproic acid) for improved pharmacokinetics. | — |
| 7 | GH Research Provider of therapeutics for the management of mental diseases | $125M | 62 mo ago | 32 | Magnus Halle Co-Founder & Managing Director | DrupalProton MailApple iCloud Mail+24 | — | — |
| 8 | Opsona Drug development company specialising in the human immune system | $82M | 152 mo ago | 18 | Kingston Mills Co-founder | — | — | — |
| 9 | Nuritas Developer of natural active ingredients with scientifically proven health benefits | $71M | 18 mo ago | 45 | — | WordPressApple iCloud MailMySQL+22 | 143 patents Discovery and formulation of bioactive peptides for therapeutic metabolic and cardiovascular applications | 1 launch |
| 10 | Amarin Developer of therapies to treat cardiovascular disorders | $70M | 113 mo ago | 365 | Patrick Holt CEO & President | DrupalApple iCloud MailPHP+21 | 31 patents Combination cardiovascular drugs: hydroxy‑statin derivatives with omega‑3 fatty acid oils. | — |
| 11 | Inflazome Developer of inhibitors for the treatment of chronic inflammatory diseases | $65M | 86 mo ago | 2 | — | — | 278 patents Patents concentrated in chemistry & materials | — |
| 12 | Sublimity Therapeutics Developer of drugs for gastrointestinal and immunological diseases | $64M | 97 mo ago | 50 | — | — | 44 patents Oil-based pharmaceutical formulations for cyclosporin immunosuppressant delivery | — |
| 13 | Horizon Therapeutics Developer of drugs for treating rare and autoimmune diseases | $62M | 140 mo ago | 2,190 | Timothy Walbert Chairman | — | 150 patents Therapeutics targeting autoimmune, inflammatory and ocular diseases via antibodies and IGF‑1R inhibitors | — |
| 14 | Aerska Developer of RNAi medicines, delivered systemically, for treating brain diseases | $60M | 4 mo ago | — | David Hardwicke Co-Founder & Director & Head of Business Development | WebflowGSAPMicrosoft Advertising+11 | — | 1 internship · 1 expansion · 1 award |
| 15 | Prothena Provider of antibody treatment for AL amyloidosis, parkinson’s disease, and psoriasis | $50M | 99 mo ago | 127 | — | WordPressMySQLSalesforce+34 | — | — |
| 16 | Alkermes Developer of small molecule therapeutics and drug delivery technologies for multiple CNS diseases | $46M | 188 mo ago | 1,775 1,775 → 2,429 (+37%) | — | DrupalApple iCloud MailPHP+23 | 13 patents Sustained‑release injectable peptide formulations and improved injectable suspension technologies. | — |
| 17 | Neuromod Devices Provider of neuromodulation treatment for tinnitus | $44M | 15 mo ago | 47 | Ross O'Neill Founder & CEO | ZohoGoogle MapsApache HTTP Server+8 | 58 patents Auditory neuromodulation devices for treating hearing and related neurological disorders | 1 launch |
| 18 | LUMA Vision Developer of interventional cardiac imaging devices | $42M | 30 mo ago | 50 | Fionn Lahart Co-Founder and Chief Executive Officer | WordPressMySQLPHP+16 | 10 patents Advanced ultrasound imaging and patient-specific anatomical modeling for lesion detection and analysis. | — |
| 19 | ProVerum Medical Developer of a minimally-invasive medical device for benign prostatic hyperplasia | $38M | 9 mo ago | 24 | Conor Harkin Co-Founder and CSO | WixSentryApple iCloud Mail+13 | — | 2 job openings |
| 20 | Priothera Developer of therapeutics for the treatment of hematological malignancies | $35M | 11 mo ago | 20 | Brice Suire Co-Founder | WordPressPleskApple iCloud Mail+18 | 54 patents Therapeutics for preventing hematologic cancer recurrence post‑stem cell transplant using S1P modulators | — |
| 21 | Avectas Provider of non-viral cell engineering technology platform for drug discovery | $33M | 73 mo ago | 35 | Michael Maguire Co-Founder & CEO | WebflowGSAPAmazon Web Services+12 | 102 patents Non-viral intracellular delivery platforms for gene editing and therapeutic payloads | 1 partnership |
| 22 | CroiValve Developer of a percutaneous device for treating tricuspid regurgitation | $32M | 11 mo ago | 28 | Lucy Okeeffe Co-Founder & CEO | WordPressMySQLPHP+17 | 16 patents Transcatheter cardiac valve replacement devices with anti‑migration delivery systems | — |
| 23 | Deciphex Network of pathologists providing digital diagnostic services for medical testing | $25M | 8 mo ago | 119 | Donal O’Shea Co-Founder & CEO | WebflowGSAPLenis+14 | 8 patents AI-powered histopathology image analysis for anomaly detection and automated tissue screening | 1 launch |
| 24 | Kypha in-vitro diagnostic biomarker tests for inflammation and autoimmune disease | $19M | 90 mo ago | 9 | — | — | — | — |
| 25 | DS Biopharma Provider of a lipid technology platform for atopic dermatitis | $16M | 171 mo ago | 10 | Ronan Lambe Co-Founder | — | 69 patents Therapeutic fatty‑acid derivative formulations (e.g., DGLA, 15‑HETrE) for pharmaceutical use | — |
| 26 | IdentiGEN Data-driven solutions for animal health, food safety, and traceability | $15M | 133 mo ago | 60 | — | — | 41 patents Automated biological sample collection and traceability systems for livestock and element analysis | 1 launch · 1 partnership |
| 27 | HiberGene Developer of molecular diagnostic tests for detecting human infectious diseases | $14M | 74 mo ago | 12 | — | — | — | — |
| 28 | BiancaMed Developer of a non-contact device to monitor sleep and breathing | $13M | 204 mo ago | 29 | — | — | 36 patents Contactless physiological and cardiorespiratory monitoring for chronic disease management | — |
| 29 | Kastus Developer of antiviral and antimicrobial surface coatings | $12M | 46 mo ago | 9 | — | — | — | — |
| 30 | HAON Developer of cell therapies to treat adult and pediatric diseases | $12M | 14 mo ago | — | Mark O'Neill Co-Founder & Director | — | — | — |
| 31 | Biosortia Natural Product Drug Discovery from unculturable aquatic microorganisms for the treatment of Cancer, CNS and… | $10M | 79 mo ago | — | Ross Youngs Interim CEO | — | — | 1 partnership |
| 32 | Biosensia Point-of-care in vitro diagnostics for immunoassays | $10M | 131 mo ago | 17 | — | — | — | — |
| 33 | RemedyBio Provider of personalised, cell based, autologous and anti-tumour therapy | $9M | 48 mo ago | 18 | Daniel Crowley CEO | — | — | — |
| 34 | Genable Technologies Provider of gene therapy to treat Retinitis pigmentosa | $8M | 175 mo ago | 5 | Paul Kenna Co-Founder | — | — | — |
| 35 | Vasorum Developer of an arterial closure device | $7M | 63 mo ago | 16 | — | — | 10 patents Surgical wound closure and tissue coupling devices for hemostasis and fluid management | — |
| 36 | OncoMark Provider of tissue-based diagnostics for cancer | $7M | 83 mo ago | 5 | — | — | — | — |
| 37 | ATXA Therapeutics Developer of small molecules to treat Pulmonary Arterial Hypertension | $6M | 41 mo ago | 5 | — | — | 17 patents Oral drug formulations delivering thromboxane receptor antagonist therapeutics. | — |
| 38 | Ostoform Developer of mouldable seals for damaged peristomal skin | $5M | 44 mo ago | 15 | Kevin Kelleher Co-Founder & CEO | Cart FunctionalityWooCommerceWordPress+28 | 12 patents Design and improvement of ostomy bag attachment systems for medical waste management | — |
| 39 | X-Bolt Orthopaedics The Hip Fracture Fixation Company. | $4M | 31 mo ago | 7 | Brian Thornes Founder & CEO | VimeoApache HTTP ServerCloudflare+6 | — | — |
| 40 | Nemysis Solutions for iron deficiency/anemia and gluten intolerance | $4M | 7 mo ago | 8 | Danilo Casadei Massari Founder & CEO | — | 31 patents Recombinant protein production platforms and iron‑hydroxide therapeutic formulations for deficiency. | 1 award |
| 41 | EmeraMed Develops therapeutics for the treatment of mercury toxicity | $4M | 73 mo ago | 8 | Boyd E. Haley CSO & Founder | WordPressMySQLPHP+22 | 111 patents Therapeutic small‑molecule agents for neurodegenerative, pain, and metastasis treatment | — |
| 42 | Akkure Provider of a blockchain technology based online platform for genomic data analytics | $3M | 42 mo ago | 9 | Amy Hollingworth Co-Founder | — | — | — |
| 43 | SiriusXT 3D imaging of biological cells using X-rays | $3M | 65 mo ago | 23 | — | WordPressMySQLPHP+21 | — | — |
| 44 | Capri-Medical Developer of injectable devices for the treatment of neurological conditions | $3M | 52 mo ago | 5 | Fergal Ward Founder & CEO | — | 45 patents Patents concentrated in health & consumer products | — |
| 45 | Celtic Biotech Developer of therapies for the treatment of non-small-cell lung cancer | $3M | 39 mo ago | 4 | John Reid Co-Founder | — | 3 patents Stabilized crotoxin formulations for therapeutic snake‑venom derived drugs | 1 partnership |
| 46 | Selio Medical Developer of device to prevent pneumothorax during transthoracic needle biopsy | $3M | 47 mo ago | — | Colm McGarvey Co-Founder | — | — | — |
| 47 | EMBA Medical Developer of smart devices for the treatment of cardiac health diseases | $2M | 67 mo ago | 6 | — | — | 16 patents Endovascular occlusion and embolization devices for vascular sealing and neurovascular treatment | — |
| 48 | NeuroNOS Developer of a novel treatment targeting core symptoms of autism spectrum disorder | $2M | 14 mo ago | — | Amir Avniel CEO | HubSpot CMS HubHubSpotcore-js+14 | — | — |
| 49 | ClarityCX1 Provider of vertical SaaS solutions for strategic account management automation | $2M | 50 mo ago | 14 | Chris Deren Founder & CEO | — | — | — |
| 50 | biologit Provider of AI-based solution for drug pharmacovigilance | $1M | 50 mo ago | 12 | Bruno Ohana Co-founder | CTO | WordPressMySQLPHP+14 | — | 2 launchs |
Top 12 Life Sciences companies in Dublin
#1
Series A · Dublin, County Dublin · founded 2025$60Mraised▾
Developer of RNAi medicines, delivered systemically, for treating brain diseases. It focuses on targeted delivery of RNA medicines to silence genes causing harm. The company aims to preserve minds, protect memories, and enable healthier lives. It combines target biology, data-driven patient stratification, and biomarker-guided development.
- Feb 2026Series A$39M
- Oct 2025Seed$21M
- 2025Seed—
#2
Series B · Dublin, Leinster · founded 2017 · 38 employees$213.9Mraised▾
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health. The company offers keto-diet-based exogenous ketone which helps in metabolic switches and provides anti-aging properties and protection from other age-related diseases like neurodegenerative diseases, immunosenescence & cell damage. The product is C6 Ketone Di-Ester which can raise the levels of ketones in the blood to generate ketosis.
- May 2025Series B$76M
- Sep 2019Series B—
- Aug 2019Series B$100M
- Jan 2019Series B$46M
#3
Series B · Dublin, Leinster · founded 2015 · 24 employees$38.2Mraised▾
Developer of a minimally-invasive medical device for benign prostatic hyperplasia. The company offers ProVerum implant a minimally invasive device for treating the enlargement of the prostate gland causing difficulty with urination.
- Aug 2025Series B$80M
- Apr 2022Grant (prize money)$52.7K
- Jan 2022Series A$34M
- Oct 2021Grant (prize money)$57.8K
#4
Series C · Dublin, Leinster · founded 2017 · 119 employees$24.5Mraised▾
Network of pathologists providing digital diagnostic services for medical testing. These services utilize artificial intelligence to assist in the analysis of tissue samples and clinical slides. The platform integrates with existing healthcare systems to facilitate remote review of diagnostic data. By digitizing workflows, the system supports the assessment of biological samples for clinical and research purposes. The technology assists in identifying lesions and evaluating diagnostic findings to support medical decision making.
- Oct 2025Venture Debt$17.6M
- Jan 2025Series C$32.1M
- Oct 2023Venture Debt$10.5M
- Jan 2023Series B$4.2M
#5
Series B · Dublin, Leinster · founded 2016 · 28 employees$32.1Mraised▾
Developer of a percutaneous device for treating tricuspid regurgitation. The device seals the gap between the valve leaflets preventing regurgitation. The device is delivered through a vein and into the right heart, restoring the function of the tricuspid valve.
- Jul 2025Grant (prize money)$2.9M
- Jul 2025Series B$11.8M
- Aug 2024Series B$16M
- Feb 2022Series A$10.9M
#6
Series A · Dublin, Leinster · founded 2020 · 20 employees$35.5Mraised▾
Developer of therapeutics for the treatment of hematological malignancies. The company offers mocravimod, a S1P receptor modulator as an adjunctive and immune therapy in combination with allogeneic hematopoietic stem cell transplantation as a post-remission therapy for acute myeloid leukemia patients.
- Jun 2025Grant (prize money)$2M
- Feb 2022Conventional Debt$19.8M
- Oct 2020Series A$35.5M
#7
Series B · Dublin, Leinster · founded 2010 · 47 employees$43.8Mraised▾
Provider of neuromodulation treatment for tinnitus. It offers sound and tongue stimuli, intra-oral device, Bluetooth headphones, and stimulating systems. It uses patented bi-modal neuromodulation technology that helps in treating neurological disorders including chronic tinnitus and others.
- Mar 2025Series B$10.8M
- Apr 2023Venture Debt$16.4M
- Apr 2023Series B$16.4M
- Oct 2020Venture Debt—
#8
Series C · Dublin, Leinster · founded 2014 · 45 employees$70.7Mraised▾
Developer of natural active ingredients with scientifically proven health benefits. It offers functional ingredients in the food that have various therapeutic qualities, including the management of chronic metabolic syndromes using its proprietary discovery platform based on artificial intelligence and genomics. The company offers ingredients by using AI-based technology and peptidomics for discovering bioactive peptides with health benefits.
- Dec 2024Series C$42M
- Nov 2021Series B$45M
- Sep 2020Grant (prize money)$115.6K
- Jun 2020Grant (prize money)$219.9K
#9
Series A · Dublin, Leinster · founded 2015 · 8 employees$4.1Mraised▾
Nemysis is a pharma company offering solutions for with iron deficiency/anemia and gluten Intolerance. The company is focusing on developing nano-particulate food supplements for treating micro-deficiencies related diseases. The company was acquired by ExPharma Limited.
- Nov 2025Series A—
- Mar 2025Series A—
- Nov 2023Grant (prize money)$2.7M
- May 2020Series A$2.9M
#10
Funding Raised · Dublin, Leinster · founded 2022$11.7Mraised▾
Developer of cell therapies to treat adult and pediatric diseases. It offers a lead candidate which is an intranasal treatment for Neonatal Hypoxic Ischemic Encephalopathy. It also offers allogeneic candidates for neurologic, rare and other serious diseases.
- Apr 2025Grant (prize money)$11.7M
#11
Acquired · Dublin, Leinster · founded 2023$2Mraised▾
Developer of a novel treatment targeting core symptoms of autism spectrum disorder. It focuses on clinical research to develop a therapeutic intervention for autism spectrum disorder. Preclinical work indicates a potential reversal of ASD-like phenotypes by targeting Nitric Oxide production. The company's research includes clinical and human stem cell samples, showing similar results. The team applies experience in neuroscience and drug therapy to provide a safe and effective therapeutic intervention for ASD.
- Mar 2025Seed$2M
#12
Series A · Dublin, Leinster · founded 2017 · 50 employees$42.3Mraised▾
Developer of interventional cardiac imaging devices. It offers VERAFEYE that leverages the power of ultrasound for soft tissue imaging through proprietary computational processing, to provide intracardiac and endovascular navigation.
- Dec 2023Series A$22M
- Oct 2021Grant (prize money)—
- Oct 2021Series A$8M
- Oct 2020Grant (prize money)$2.9M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding flat · growth flat
How research on Biotechnology in Dublin is moving
A read on the academic research around Biotechnology in Dublin — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 48 papers.
University College Dublin, Trinity College Dublin, and Technological University Dublin lead Dublin's moderately optimistic biotechnology research, focusing predominantly on protein science, bioactive peptides, and antibody development.
- University College Dublin31
- Trinity College Dublin9
- Technological University Dublin9
- Dublin Dental University Hospital1
- Mutation2
- Mutant2
- Cell biology2
- Fungicide1
- Mycosphaerella graminicola1
- Crop3
- Gene expression2
- Bioconversion2
- Hydrolysate2
- Valorisation2
- Sustainability2
- Modified atmosphere1
- Active packaging1
- Postharvest1
- Standardization1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.